“Off-Label” Stent Therapy: 2-Year Comparison of Drug-Eluting Versus Bare-Metal Stents
- 12 February 2008
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 51 (6) , 607-614
- https://doi.org/10.1016/j.jacc.2007.08.064
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Unanswered Questions — Drug-Eluting Stents and the Risk of Late ThrombosisNew England Journal of Medicine, 2007
- Stent Thrombosis Redux — The FDA PerspectiveNew England Journal of Medicine, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Estimating Treatment Effects Using Observational DataJAMA, 2007
- Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent ImplantationJAMA, 2007
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsPublished by Elsevier ,2006
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJournal of the American College of Cardiology, 2006
- Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting StentsCirculation, 2005
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003